SCHEMBL7010160

SCHEMBL7010160

CCOc1nc2c(C(=O)OC)sc(C)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
RXFP1 Q9HBX9 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 5/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 1/20 0.36
HSD17B10 Q99714 4/20 0.34
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 5/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TSHR P16473 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010158 0.89 KDM4E (0.39) KDM4ERXFP1NPC1RAB9ANPSR1
SCHEMBL7012345 0.77 CSNK2A2 (0.41) KDM4EKMT2AALDH1A1MAPTMEN1
SCHEMBL9031610 0.75 CSNK2A2 (0.40) NPSR1KMT2AALDH1A1MAPTMEN1
SCHEMBL9031781 0.75 CSNK2A2 (0.41) KDM4ERXFP1NPC1RAB9AKMT2A
SCHEMBL9031446 0.74 KDM4E (0.41) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL9033551 0.74 TSHR (0.46) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL9032187 0.72 KDM4E (0.33) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL9031878 0.72 KMT2A (0.34) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL9031572 0.72 XDH (0.44) CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL9032280 0.71 HPGD (0.44) KDM4ERAB9AKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed